Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.